288 related articles for article (PubMed ID: 32991878)
1. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Narula S; Tandon S; Kumar D; Varshney S; Adlakha K; Sengupta S; Singh SK; Tandon C
Life Sci; 2020 Dec; 262():118498. PubMed ID: 32991878
[TBL] [Abstract][Full Text] [Related]
2. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
[TBL] [Abstract][Full Text] [Related]
3. Novel antilithiatic cationic proteins from human calcium oxalate renal stone matrix identified by MALDI-TOF-MS endowed with cytoprotective potential: an insight into the molecular mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
Clin Chim Acta; 2013 Jan; 415():181-90. PubMed ID: 23123287
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
Priyadarshini ; Singh SK; Tandon C
Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
[TBL] [Abstract][Full Text] [Related]
5. Human kidney stone matrix: Latent potential to restrain COM induced cytotoxicity and inflammatory response.
Narula S; Tandon S; Baligar P; Singh SK; Tandon C
Chem Biol Interact; 2017 Dec; 278():114-122. PubMed ID: 29054323
[TBL] [Abstract][Full Text] [Related]
6. 2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.
Aggarwal KP; Tandon S; Singh SK; Tandon C
Int Braz J Urol; 2013; 39(1):128-36. PubMed ID: 23489505
[TBL] [Abstract][Full Text] [Related]
7. Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney.
Duan X; Kong Z; Mai X; Lan Y; Liu Y; Yang Z; Zhao Z; Deng T; Zeng T; Cai C; Li S; Zhong W; Wu W; Zeng G
Redox Biol; 2018 Jun; 16():414-425. PubMed ID: 29653411
[TBL] [Abstract][Full Text] [Related]
8. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.
Wesson JA; Johnson RJ; Mazzali M; Beshensky AM; Stietz S; Giachelli C; Liaw L; Alpers CE; Couser WG; Kleinman JG; Hughes J
J Am Soc Nephrol; 2003 Jan; 14(1):139-47. PubMed ID: 12506146
[TBL] [Abstract][Full Text] [Related]
10. Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion.
Kanlaya R; Fong-Ngern K; Thongboonkerd V
J Proteomics; 2013 Mar; 80():55-65. PubMed ID: 23352899
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
[No Abstract] [Full Text] [Related]
12. Effect of biomolecules from human renal matrix of calcium oxalate monohydrate (CaOx) stones on in vitro calcium phosphate crystallization.
Pathak P; Singh SK; Tandon C
Int Braz J Urol; 2010; 36(5):621-8. PubMed ID: 21044380
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet.
Liu CJ; Tsai YS; Huang HS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328466
[TBL] [Abstract][Full Text] [Related]
14. Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone.
Zhang X; Liang F; Li T; Jiang Y; Ren F
Arch Biochem Biophys; 2023 May; 739():109568. PubMed ID: 36914110
[TBL] [Abstract][Full Text] [Related]
15.
An L; Wu W; Li S; Lai Y; Chen D; He Z; Chang Z; Xu P; Huang Y; Lei M; Jiang Z; Zeng T; Sun X; Sun X; Duan X; Wu W
Oxid Med Cell Longev; 2021; 2021():9949697. PubMed ID: 34336124
[No Abstract] [Full Text] [Related]
16. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque.
O'Kell AL; Lovett AC; Canales BK; Gower LB; Khan SR
Urolithiasis; 2019 Aug; 47(4):335-346. PubMed ID: 30218116
[TBL] [Abstract][Full Text] [Related]
17. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
Khan SR; Glenton PA; Backov R; Talham DR
Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
[TBL] [Abstract][Full Text] [Related]
18. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
19. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs.
Li S; Macaringue EGJ; Zhou D; Shi P; Tang W; Gong J
J Ethnopharmacol; 2022 Feb; 284():114733. PubMed ID: 34644589
[TBL] [Abstract][Full Text] [Related]
20. Kidney stone matrix proteins ameliorate calcium oxalate monohydrate induced apoptotic injury to renal epithelial cells.
Narula S; Tandon S; Singh SK; Tandon C
Life Sci; 2016 Nov; 164():23-30. PubMed ID: 27593572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
